Ozempic: The rising costs and coverage issues of weight loss medication
Recently, medications like Ozempic and Wegovy, which can help with weight loss, have become very popular. However, some health insurance companies and employers are stopping coverage for these drugs because they are expensive.
Some commentators argue that this approach is unfair and that it's unlikely insurance companies would stop coverage for expensive medications used to treat other chronic illnesses. Some experts argue that the position being adopted by some insurers is adding to the stigma around obesity.
Dr. Angela Fitch believes that pharmaceutical companies, insurers, and healthcare providers need to work together to create sustainable options for patients.
Obesity is a chronic condition requiring ongoing treatment. While GLP-1 drugs can be very helpful, they only work if the patient continues taking them. Dr. Fitch points out that people seeking quick weight loss might feel disappointed if they don’t consider the long-term need for these medications. There are also concerns that the decision to stop funding such treatment could lead to higher costs down the line if obesity leads to other complications which are covered under policies.
What does this mean for insurers?
Insurers will no doubt be considering their own approach to the funding (or not) of such treatments. When deciding on their approach, insurers will need to weigh up a number of competing factors such as the cost of treatment, the potential long term costs of not funding treatment, and customers’ expectations.
Contents
- The Word, October 2024
- Updates to the UK’s Arbitration Bill
- ICAEW: Changes to PII requirements
- What does the Employment Rights Bill mean for employment practices liability insurance?
- Contractor insolvency: Peabody Trust v NHBC
- Insurability by design: Increased transparency for vehicle manufacturers and insurers
Author
Alex Morrissey
Insurance Wording Technician
alex.morrissey@brownejacobson.com
+44 (0)330 045 2897
Related expertise
You may be interested in...
°ÄÃÅÁùºÏ²Ê×ÊÁÏ
The ‘grate’ cheese robbery: Implications for insurance professionals
°ÄÃÅÁùºÏ²Ê×ÊÁÏ
Environmental crime and the impact for insurers
°ÄÃÅÁùºÏ²Ê×ÊÁÏ
What might a Trump victory mean for the UK insurance industry?
°ÄÃÅÁùºÏ²Ê×ÊÁÏ
Post Office scandal: Lessons for underwriters
°ÄÃÅÁùºÏ²Ê×ÊÁÏ
Weather protection parametric insurance: A sign of things to come?
°ÄÃÅÁùºÏ²Ê×ÊÁÏ - The Word
The Word, November 2024
°ÄÃÅÁùºÏ²Ê×ÊÁÏ - The Word
The Word, October 2024
°ÄÃÅÁùºÏ²Ê×ÊÁÏ
Updates to the UK’s Arbitration Bill
°ÄÃÅÁùºÏ²Ê×ÊÁÏ
Ozempic: The rising costs and coverage issues of weight loss medication
°ÄÃÅÁùºÏ²Ê×ÊÁÏ
ICAEW: Changes to PII requirements
°ÄÃÅÁùºÏ²Ê×ÊÁÏ
Contractor insolvency: Peabody Trust v NHBC
°ÄÃÅÁùºÏ²Ê×ÊÁÏ
By a narrow 2 to 1 majority, the Court of Appeal finds in favour of insurers in the construction of an exclusion clause in a W&I policy
°ÄÃÅÁùºÏ²Ê×ÊÁÏ
LMA binders’ consultation
°ÄÃÅÁùºÏ²Ê×ÊÁÏ
Smooth sailing ahead: The LMA's new Open Form Default Clause
°ÄÃÅÁùºÏ²Ê×ÊÁÏ
PFAS: The issue that won’t go away
°ÄÃÅÁùºÏ²Ê×ÊÁÏ
Oklahoma earthquake: Racial discrimination in adjudication
°ÄÃÅÁùºÏ²Ê×ÊÁÏ
Vicarious liability for kinship foster carer abuse: Implications for local authority insurers
°ÄÃÅÁùºÏ²Ê×ÊÁÏ - The Word
The Word, September 2024
°ÄÃÅÁùºÏ²Ê×ÊÁÏ
Latest short-term insurance trends
°ÄÃÅÁùºÏ²Ê×ÊÁÏ - The Word
The Word, August 2024
°ÄÃÅÁùºÏ²Ê×ÊÁÏ
Words matter: Another case on the importance of accurate drafting
°ÄÃÅÁùºÏ²Ê×ÊÁÏ
London Fire Brigade to stop attending for automatic fire alarms: Implications for insurers
°ÄÃÅÁùºÏ²Ê×ÊÁÏ
Navigating Oil Price Cap legislation: LMA issues revised Cargo and Hull wordings
°ÄÃÅÁùºÏ²Ê×ÊÁÏ - The Word
The Word, July 2024
°ÄÃÅÁùºÏ²Ê×ÊÁÏ
Multi-occupancy building insurance: Latest tribunal decision
°ÄÃÅÁùºÏ²Ê×ÊÁÏ - The Word
The Word, June 2024
°ÄÃÅÁùºÏ²Ê×ÊÁÏ - Consumer Duty
Updated UK Consumer Wordings Guidance: °ÄÃÅÁùºÏ²Ê×ÊÁÏ collaborates with the LMA
°ÄÃÅÁùºÏ²Ê×ÊÁÏ - Consumer Duty
From products to protection: The rise of embedded insurance
°ÄÃÅÁùºÏ²Ê×ÊÁÏ
The European Accessibility Act: Inclusive products and services
°ÄÃÅÁùºÏ²Ê×ÊÁÏ
Final FCA anti-greenwashing rule guidance published
°ÄÃÅÁùºÏ²Ê×ÊÁÏ - The Word
The Word, May 2024
°ÄÃÅÁùºÏ²Ê×ÊÁÏ
New guidance on supporting autistic customers for the insurance industry
°ÄÃÅÁùºÏ²Ê×ÊÁÏ
Chubb ordered to indemnify SXSW for Covid cancellation
°ÄÃÅÁùºÏ²Ê×ÊÁÏ - The Word
The Word, April 2024
°ÄÃÅÁùºÏ²Ê×ÊÁÏ - The Word
The Word, March 2024
°ÄÃÅÁùºÏ²Ê×ÊÁÏ
Commercial Court considers requests for stay or anti-suit injunction where two competing reinsurance wordings
°ÄÃÅÁùºÏ²Ê×ÊÁÏ
Insurers prevail once more in construction of an exclusion clause in W&I policy
°ÄÃÅÁùºÏ²Ê×ÊÁÏ
Parametric flood policies - Insurers no longer in uncharted waters?
°ÄÃÅÁùºÏ²Ê×ÊÁÏ
LockBit unlocked: °ÄÃÅÁùºÏ²Ê×ÊÁÏ taskforce takes down major cyber criminal organisation
